Kerrison, Caroline, Wright, Francesca, Piper, Joseph, Kumar, Ram and Hawcutt, Daniel B ORCID: 0000-0002-8120-6507
(2014)
Efficacy and tolerability of zolmitriptan oro-dispersible wafer in treatment of childhood migraine.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 21 (2).
pp. 84-86.
This is the latest version of this item.
Text
Zolmitriptan manuscript v5.0.doc - Unspecified Download (113kB) |
Abstract
Introduction Migraine affects 8% of children, and may require pharmacological therapy to control symptoms. Current acute treatments include (5-Hydroxytryptamine Receptor 1 (5-HT1) receptor agonists, although the only licensed medication for paediatric patients in this class in the UK is intranasal sumatriptan. Oro-dispersible wafers of zolmitriptan are used in practice but have not been evaluated in the paediatric setting. Methods A prospective case note audit of orodispersible zolmitriptan wafers use in the treatment of paediatric migraine by a consultant paediatric neurologist was carried out. Results Symptomatic benefit was noted in 71.4% (n=10) of patients who have been prescribed the orodispersible wafer formulation. All subgroups of migraine included in the audit had some participants who benefitted from the medication. Five patients (35.7%) complained of mild adverse effects: nausea (n=2, 14.3%); Somnolence (n=2, 14.3%); Tingling sensation on the tongue (n=1, 7.1%). No patients had any severe adverse effects. Conclusions In children with migraine treated in a tertiary paediatric neurology setting, the oro-dispersible wafer formulation of zolmitriptan is effective and well tolerated. Adequately powered prospective studies are required to determine the optimal place for this medication in paediatric migraine management.
Item Type: | Article |
---|---|
Additional Information: | ## TULIP Type: Articles/Papers (Journal) ## |
Uncontrolled Keywords: | Neurosciences, Chronic Pain, Pain Research, Migraines, Headaches, 6.1 Pharmaceuticals, 6 Evaluation of treatments and therapeutic interventions |
Subjects: | ?? RJ101 ?? ?? RM ?? ?? RS ?? |
Depositing User: | Symplectic Admin |
Date Deposited: | 08 Jan 2016 11:48 |
Last Modified: | 14 Mar 2024 22:46 |
DOI: | 10.1136/ejhpharm-2013-000347 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/2045339 |
Available Versions of this Item
- Efficacy and tolerability of zolmitriptan oro-dispersible wafer in treatment of childhood migraine. (deposited 08 Jan 2016 11:48) [Currently Displayed]